PharmaLive Special Reports
Canon Communications LLC is a leading publisher, trade show producer, and digital media and data company for the pharmaceutical, medical manufacturing, general design, microelectronics, and packaging industries. Canon leverages the expertise, knowledge, and data acquired in the process of producing leading trade information resources to produce in-depth special reports for the purposes of market research, industry research, business analysis, competitive intelligence, and business development.
Canon Communications produces an extensive collection of print publications, trade shows, and digital resources including: Med Ad News, R&D Directions, Medical Device & Diagnostic Industry, IVD Technology, Medical Device Technology, MX, Pharmaceutical and Medical Packaging News, Appliance Magazine, PharmaLive.com, DeviceLink.com, MDRWeb.com, eKnowledgeBase, and more.
|
|
List of reports from PharmaLive Special Reports
From Pipeline to Market 2007
6/1/2007 | published by: PharmaLive Special Reports
... drugs are separated into sections by their approved or development status. Each section provides the product's commercial name or product code, chemical or substance composition, the approved or intended application, and developer with company website.
|
read more...
|
$445.00
|
Drug Approvals Over Time 2007
2/7/2007 | published by: PharmaLive Special Reports
... drug application or biologics license application. These medicines include new molecular entities, biotechnology drugs, biologicals, imaging agents, branded generics, and branded formulations of existing products. Excluded from this list are nonbranded generics approved via an ...
|
read more...
|
$195.00
|
Top 50 Companies That Specialize
12/1/2006 | published by: PharmaLive Special Reports
... 50 specialty companies that are publicly traded and report their financial information. The rankings of each specialty company include total revenue, net income, earnings, location, website and the main area of concentration for the business.
|
read more...
|
$195.00
|
Top 15 Therapeutic Categories 2006
10/1/2006 | published by: PharmaLive Special Reports
... awaiting approval and clinical trials status in the United States. Each unique product is detailed - including the phase it is in, the primary disease it treats, and the developer/partner developer of the respective drug.
|
read more...
|
$445.00
|
Top 15 Japanese Pharmaceutical Company Pipelines 2006
10/1/2006 | published by: PharmaLive Special Reports
... each product: chemical or substance composition, intended indication, clinical status, region of development, and developer/marketer. All phases of development, concentrating on products in development in Japan, Europe, and the United States, have been considered for ...
|
read more...
|
$295.00
|
Top 50 Pharmaceutical Companies and Their Pipelines for 2006
9/1/2006 | published by: PharmaLive Special Reports
... special report provide the following for each product: chemical or substance composition, intended indication, clinical status, region of development, and developer/marketer. All phases of development, concentrating on products in development in the United States, Europe, ...
|
read more...
|
$445.00
|
Top 500 Prescription Medicines by Worldwide Sales - 2006
6/1/2006 | published by: PharmaLive Special Reports
... prescription medicines that pharmaceutical, biotechnology, and specialty companies manufacture and sell. The information in this report is supplied by the companies. This document provides information on 500 product sales entries representing more than 75 companies. ...
|
read more...
|
$445.00
|
Account Rosters: Health-Care Advertising Agencies & Their Rosters 2006
5/1/2006 | published by: PharmaLive Special Reports
... agencies regarding the product and corporate advertising accounts that they promote. This annual report provides information on thousands of accounts from more than 400 pharmaceutical, biotechnology, diagnostic, device and other companies serviced by the healthcare ...
|
read more...
|
$445.00
|
|
Join Alert Me now! Receive bi-weekly email alerts on new market research Sign up today!
|
